The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

Jul. 18, 2018
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Université DE Montpellier, Montpellier, FR;

Inventors:

Krzysztof Rogowski, Montpellier, FR;

Siem Van Der Laan, Cazilhac, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/81 (2006.01); A61K 38/00 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61P 21/00 (2006.01); A61P 25/28 (2006.01); C07K 1/14 (2006.01); C12N 9/48 (2006.01); C12Q 1/37 (2006.01);
U.S. Cl.
CPC ...
C07K 14/8103 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61P 21/00 (2018.01); A61P 25/28 (2018.01); C07K 1/14 (2013.01); C12N 9/485 (2013.01); C12Q 1/37 (2013.01); C12Y 304/17017 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention relates to a method for purifying proteins having a tubulin carboxypeptidase activity from a biological extract, comprising polymerization/depolymerization cycle performed on a biological extract in presence of microtubules. The invention further relates to a peptidic based inhibitor for use in the treatment of a disorder involving altered microtubule detyrosination in an animal, wherein the peptidic based inhibitor comprises a peptidic moiety constituted of 1 to 20 amino acids, said peptidic moiety having an amino acid selected from Y or F at the C-terminal position, and wherein the peptidic based inhibitor inhibits at least partially a tubulin carboxypeptidase activity.


Find Patent Forward Citations

Loading…